Drug
Salmon calcitonin clinical trials
Also written Miacalcin.
How studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 3 |
| 2011 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 5
Nordic Bioscience A/S (5) · Novartis (4) · University of Missouri-Columbia (1) · Yale University (1) · Tarsa Therapeutics, Inc. (1) · Rene Rizzoli (1) · Eli Lilly and Company (1) · Université Catholique de Louvain (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses salmon calcitonin is read from its arms, and is right about nine times in ten.
Testing it · 16
- The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring InjuriesCompletedPhase 4University of Missouri-ColumbiaNCT03812991Written as Miacalcin Calcitonin Salmon Nasal Spray
- Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee OsteoarthritisCompletedPhase 3Nordic Bioscience A/SNCT00486434Written as SMC021 Oral Calcitonin
- Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)TerminatedPhase 3Nordic Bioscience A/SNCT00704847Written as Oral Salmon Calcitonin
- Calcitonin for Treating X-linked HypophosphatemiaCompletedNot applicableYale UniversityNCT01652573Written as nasal salmon calcitonin
- Calcitonin in the Treatment of FibromyalgiaWithdrawnPhase 4Unidad de Investigacion en Enfermedades Cronico-DegenerativasNCT00754884Written as salmon calcitonin
- A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal WomenCompletedPhase 2Tarsa Therapeutics, Inc.NCT00803686Written as Fortical (rsCT) nasal spray
- A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin DCompletedPhase 3Nordic Bioscience A/SNCT00525798Written as SMC021 Oral calcitonin
- Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal WomenCompletedPhase 3Rene RizzoliNCT00372099Written as Salmon calcitonin
- Comparison Medications in the Treatment of Postmenopausal Women With OsteoporosisCompletedPhase 3Eli Lilly and CompanyNCT00542984Written as salmon calcitonin 100 IU/day subcutaneous
- Drug Interaction of SMC021 With Concomitant Antacid (Calcium Carbonate/Magnesium Hydroxide).CompletedPhase 2NovartisNCT00421590Written as SMC021
- SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days StudyCompletedPhase 1Nordic Bioscience A/SNCT00486369Written as Oral salmon calcitonin
- Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With OsteoarthritisCompletedPhase 1Nordic Bioscience A/SNCT00486317Written as Oral salmon calcitonin, salmon calcitonin nasal spray
- Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal WomenCompletedPhase 1NovartisNCT00395395Written as Oral salmon calcitonin, salmon calcitonin nasal spray
- Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal WomenCompletedPhase 1NovartisNCT00411125Written as Oral salmon calcitonin
- Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal WomenCompletedPhase 4NovartisNCT00239889Written as Salmon calcitonin
- Effects of Oral Salmon Calcitonin in Human OsteoarthritisTerminatedPhase 2Université Catholique de LouvainNCT00376311Written as oral salmon calcitonin
As the comparator · 3 — what is tested is compared with salmon calcitonin
- A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal WomenCompletedPhase 2Tarsa Therapeutics, Inc.NCT00620854Written as Recombinant Salmon Calcitonin (rsCT)
- A Study for Patients With OsteoporosisCompletedPhase 3Eli Lilly and CompanyNCT00414973Written as Salmon Calcitonin
- A Study of the Treatment of Postmenopausal Women With OsteoporosisCompletedPhase 3Eli Lilly and CompanyNCT00543023Written as salmon calcitonin 100 IU/day subcutaneous
Codes
What other systems call salmon calcitonin · ClinicalTrials.gg INT002880
- MeSH (NLM) C028815salmon calcitoninConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7SFC6U2VI5CALCITONIN SALMONConfirmed FDA, NLM, Wikidata
- RxNorm 36118Confirmed FDA, Wikidata
- Wikidata Q20801721salmon calcitoninConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C329Calcitonin SalmonConfirmed FDA, Wikidata
- DrugBank DB00017One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C028815 | salmon calcitonin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7SFC6U2VI5 | CALCITONIN SALMON | Confirmed FDA, NLM, Wikidata |
| RxNorm | 36118 | — | Confirmed FDA, Wikidata |
| Wikidata | Q20801721 | salmon calcitonin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C329 | Calcitonin Salmon | Confirmed FDA, Wikidata |
| DrugBank | DB00017 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.